Patterns of use of adjuvant therapy in patients with stage 1 NSGCT (#11)

11:00 AM

Mun Sem Liew

A giant leap - Part l: Prostate and Germ Cell Tumours

Population based analysis of Prostate Specific Antigen (PSA) screening in younger men in Australia (#17)

3:30 PM

Weranja Ranasinghe

Best of the best orals

Prospective analysis of the impact of a uro-oncology multi-disciplinary meeting on clinical decision making (#16)

2:00 PM

Kenny Rao

Trials, tribulations and teamwork

Treatment outcome for stage 1 seminoma at single tertiary institution experience (#111)

5:00 PM

Mun Sem Liew

Poster walkabout

The effects of non-specific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer (#119)

5:00 PM

Weranja Ranasinghe

Poster walkabout

Patients' and their doctors’ preferences for adjuvant sorafenib after resection of intermediate to high risk RCC: what makes it worthwhile? (#121)

5:00 PM

Shomik Sengupta

Poster walkabout